NCT03428698

Brief Summary

Objective: The study aimed to assess the effect of topical application of an amino acid + sodium hyaluronate acid gel after lower third molar extraction. Study design: 136 patients requiring lower third molar extraction were enrolled. An amino acid + sodium hyaluronate acid (HA) gel was applied to the sockets of the patients in the treatment group immediately following extraction; the sockets of the controls were simply flushed with a sterile saline solution. 7 and 14 days after surgery, patients' outcomes and postoperative complications were evaluated. Cumulative incidence of dehiscence and secondary outcome measures were analyzed using a chi-square test.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
136

participants targeted

Target at P75+ for not_applicable pain

Timeline
Completed

Started Sep 2009

Typical duration for not_applicable pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 10, 2009

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2010

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 25, 2011

Completed
6.2 years until next milestone

First Submitted

Initial submission to the registry

February 4, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 12, 2018

Completed
Last Updated

February 12, 2018

Status Verified

February 1, 2018

Enrollment Period

1 year

First QC Date

February 4, 2018

Last Update Submit

February 9, 2018

Conditions

Keywords

third molar extractionhyaluronic acid

Outcome Measures

Primary Outcomes (1)

  • cumulative incidence of dehiscence

    Surgical wound dehiscence is defined as a pathologic process consisting of a partial or complete disruption of the buccal and lingual mucosa layers of a surgical wound.

    14 days

Study Arms (2)

experimental device

EXPERIMENTAL

The extraction was completed, the socket was filled with a topical amino acid + sodium hyaluronate gel (Aminogam®, sterile syringe 2 ml).

Device: Aminogam

control no device

PLACEBO COMPARATOR

The extraction was completed, socket was flushed, using a 2ml sterile syringe similar to one utilized to apply the gel, with sterile physiological solution.

Device: Aminogam

Interventions

AminogamDEVICE

A lower third molar was extracted. All the surgical tools and materials as well as the surgical field were sterile. A full-thickness flap was raised and, if necessary, osteotomy and tooth sectioning were performed using a straight handpiece with dedicated burs under copious irrigation with sterile saline solution. The extraction was completed with curved and straight extractors, the socket was closely inspected and the dental follicle was removed. Depending on the group to which the patient was assigned, one of the following procedures was carried out.

control no deviceexperimental device

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • age 18 between 25 years,
  • ASA I or II,
  • necessitating lower wisdom tooth extraction,
  • no evidence of inflammation

You may not qualify if:

  • smoking more than 10 cigarettes a day,
  • pregnancy,
  • uncontrolled diabetes mellitus,
  • any diseases contraindicating the surgical procedure,
  • use of bisphosphonate,
  • antibiotics or NSAIDs during the 30 days preceding surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Padova

Padua, 35100, Italy

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Stefano Sivolella, DDS, PhD

    University of Padova

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
DDS, PhD, MSc

Study Record Dates

First Submitted

February 4, 2018

First Posted

February 12, 2018

Study Start

September 10, 2009

Primary Completion

September 10, 2010

Study Completion

November 25, 2011

Last Updated

February 12, 2018

Record last verified: 2018-02

Data Sharing

IPD Sharing
Will not share

Locations